KLOVINAL

This brand name is authorized in Nigeria.

Active ingredients

The drug KLOVINAL contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 140QMO216E - METRONIDAZOLE
 

Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites.

 
Read more about Methronidazole
2
UNII G07GZ97H65 - CLOTRIMAZOLE
 

Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc.

 
Read more about Clotrimazole
3
 
Read more about Lactic acid bacteria

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-9613 Pessary Klovinal Pessaries SUPP 500 mg; 100 mg; 150 million spores 1 x 6's (in PVC-PE foil) Vaginal pessary 30/04/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
G01AF01 Metronidazole G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AF Imidazole derivatives
Discover more medicines within G01AF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-9613

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.